HansBiomed Corporation

HansBiomed Corporation

042520 · KQ · Healthcare / Medical Devices

12,560.00KRW-1010.00 (-7.44%)

Price History

Full chart

Market Stats

Previous Close13,570.00
Open13,570.00
Day Range12,310.00 – 14,010.00
52-Week Range15,300.00 – 57,800.00
Volume438.72K
Market Cap310.18B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.99
50-Day Avg19,687.00
200-Day Avg29,227.25

About

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Guen Young Kim
  • Employees315
  • Headquarters7, Jeongui-ro 8-gil, Seoul, South Korea, 05836, Korea
  • Websitehttps://www.hansbiomed.com

Leadership

  • Seok-Bae OhChief Financial Officer and Managing Director · b. 1971
  • Mr. Won-Gyun KwonSenior MD & Director · b. 1954
  • Mr. Guen Young KimChief Executive Officer

Financials

Income Statement

Currency: KRW2012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue17.58B20.07B21.03B23.43B29.05B39.06B51.75B66.99B80.10B59.10B74.46B78.03B81.14B89.78B
Growth (%)-+14.14%+4.82%+11.39%+23.99%+34.46%+32.49%+29.46%+19.57%-26.22%+25.99%+4.80%+3.98%+10.65%
Cost of Revenue9.63B11.01B10.82B12.75B15.63B20.77B24.47B26.84B37.58B29.87B28.78B32.91B29.39B38.27B
Gross Profit--9.57B10.68B13.41B18.29B27.28B40.15B42.52B29.23B45.68B45.12B51.75B51.51B
Gross Margin--45.49%45.57%46.18%46.82%52.71%59.93%53.08%49.46%61.35%57.83%63.78%57.38%
Operating Expense--5.66B5.62B7.53B9.04B21.26B29.19B55.04B45.57B44.39B49.64B51.12B77.40B
Operating Income3.15B3.89B3.90B5.06B5.88B9.25B6.01B10.96B-12.53B-16.34B1.29B-4.52B630.00M-25.89B
Operating Margin17.91%19.41%18.57%21.59%20.26%23.67%11.62%16.36%-15.64%-27.66%1.74%-5.79%0.78%-28.84%
EBITDA----------14.69B-12.81B530.35M-22.81B
EBITDA Margin----------19.72%-16.42%0.65%-25.41%
Net Income2.52B3.43B3.50B4.91B4.63B7.83B4.02B9.95B-17.84B-18.29B6.15B-23.04B-7.22B-31.34B
Net Income Margin14.33%17.11%16.63%20.96%15.92%20.04%7.76%14.85%-22.27%-30.95%8.26%-29.53%-8.90%-34.91%
R&D-1.25B512.74M368.54M176.67M777.06M1.15B4.04B5.51B7.15B5.66B5.60B4.63B5.37B
R&D as % of Total Revenue-6.25%2.44%1.57%0.61%1.99%2.22%6.03%6.88%12.10%7.60%7.17%5.70%5.98%
Interest Expense000000001.37B3.50B6.28B5.52B1.78B1.83B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.71%5.92%8.44%7.08%2.19%2.04%

Balance Sheet

Currency: KRW2012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets27.05B33.36B44.34B52.11B64.72B80.19B91.80B134.09B131.81B129.44B131.69B122.37B121.72B126.41B
Total Liabilities3.01B4.05B4.95B8.95B17.90B26.46B26.49B50.03B71.47B84.99B86.05B72.42B54.59B92.52B
Total Equity24.04B29.31B39.39B43.16B46.82B53.73B65.30B74.88B60.34B44.45B45.63B49.13B66.87B33.70B
Cash2.40B2.76B1.96B1.24B4.63M2.21B1.62B10.40B9.35B3.55B15.00K6.13B7.26B8.15B
Total Debt---3.59B3.00B--33.60B32.28B50.84B----
Net Debt--------17.85B42.13B46.03B33.32B27.04B33.15B

Cash Flow

Currency: KRW2012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow1.50B2.33B2.06B3.47B-316.10M5.60B5.20B7.71B5.75B-14.64B-4.27B-3.73B1.76B318.34M
Investing Cash Flow2.72B--11.64B-5.17B-9.61B-11.39B-4.41B-33.36B-1.33B-21.19B3.17B3.32B-6.59B-
Financing Cash Flow-2.48B8.78B3.71B7.89B8.56B3.13B27.52B-1.12B29.74B1.39B-828.51M5.86B-
Capital Expenditure253.56M7.29B12.39B6.07B9.71B13.05B2.24B15.56B7.05B4.89B3.99B2.07B2.83B1.76B
Free Cash Flow---------3.41B-19.85B-8.40B-5.80B-1.07B-1.44B
Dividends Paid--847.96M941.74M941.74M941.74M941.74M981.83M1.18B-----
FCF to OCF---------59.22%135.56%196.81%155.36%-60.87%-452.11%
Dividend Paid to FCF---------34.75%-----

Earnings

Report DateDec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Dec 31, 2013Mar 31, 2014Aug 13, 2014Dec 15, 2014Feb 13, 2015May 28, 2015Aug 10, 2015Dec 30, 2015Feb 14, 2016May 15, 2016Aug 12, 2016Nov 16, 2016Feb 13, 2017Mar 31, 2017Aug 14, 2017Nov 20, 2017Feb 14, 2018May 15, 2018Aug 14, 2018Dec 4, 2018Feb 14, 2019May 15, 2019Aug 13, 2019Dec 18, 2019Feb 14, 2020May 14, 2020Aug 13, 2020Dec 29, 2020Feb 10, 2021May 13, 2021Aug 13, 2021Dec 21, 2021Feb 14, 2022May 16, 2022Aug 15, 2022Dec 19, 2022Feb 14, 2023May 15, 2023Aug 14, 2023Dec 20, 2023Feb 15, 2024May 14, 2024Aug 14, 2024Dec 18, 2024Feb 14, 2025May 15, 2025Aug 12, 2025Dec 17, 2025Feb 12, 2026May 13, 2026Jun 30, 2026
EPS Estimate----------------------------------227.00181.50215.50335.41----------------------------
EPS Actual66.7128.3177.00-31.1237.0012.0022.0046.0451.9497.99137.0082.6445.69125.4890.00129.5769.34125.3566.00134.9585.10166.84134.44129.19139.14116.58104.08314.85179.74108.50228.14136.67157.00293.00-173.00167.00195.00234.00403.54157.36-42.0015.00-1909.62270.33-735.00-182.00-1178.22-138.00341.00-54.50191.82-373.57-964.03-38.35-735.25-79.20-4.007.21-480.63-141.8264.10-250.38-2126.42153.53277.96135.47
Surprise-----------------------------------176.21%-7.99%-9.51%-30.23%----------------------------
Timing-----------------Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap310.18B
Enterprise Value276.09B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.49
Price / Book3.23
Revenue (TTM)124.81B
Gross Profit (TTM)74.65B
EBITDA-13.78B
Profit Margin-15.76%
Operating Margin11.27%
Return on Equity-29.22%
Return on Assets-8.15%
Shares Outstanding14.26M
Shares Float9.14M
Beta1.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20201×
120.00Sep 28, 2020
20191×
120.00Sep 27, 2019
20181×
100.00Sep 27, 2018
20171×
100.00Sep 28, 2017
20161×
100.00Sep 29, 2016
20151×
100.00Sep 25, 2015
20141×
100.00Sep 29, 2014
20131×
100.00Sep 27, 2013
20121×
70.00Sep 27, 2012
20111×
50.00Sep 29, 2011
20101×
50.00Sep 29, 2010